+Search query
-Structure paper
Title | Discovery and pharmacological characterization of 1,2,3,4-tetrahydroquinoline derivatives as ROR gamma inverse agonists against prostate cancer. |
---|---|
Journal, issue, pages | Acta Pharmacol. Sin., Year 2024 |
Publish date | May 7, 2022 (structure data deposition date) |
![]() | Wu, X.S. / Luo, X.Y. / Li, C.C. / Zhao, X.F. / Zhang, C. / Chen, X.S. / Lu, Z.F. / Wu, T. / Yu, H.N. / Peng, C. ...Wu, X.S. / Luo, X.Y. / Li, C.C. / Zhao, X.F. / Zhang, C. / Chen, X.S. / Lu, Z.F. / Wu, T. / Yu, H.N. / Peng, C. / Hu, Q.Q. / Shen, H. / Xu, Y. / Zhang, Y. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.57 Å |
Structure data | ![]() PDB-7xqe: |
Chemicals | ![]() ChemComp-H4I: ![]() ChemComp-GOL: ![]() ChemComp-EOH: ![]() ChemComp-HOH: |
Source |
|
![]() | DNA BINDING PROTEIN / ROR gamma / LBD / Inhibitor |